바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionFirst Trust Advisors Lp
Latest Disclosed Ownership1,672,491 shares
Latest Disclosed Value $ 94,478,985
First Trust Advisors Lp reports 43.34% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 13, 2026 - First Trust Advisors Lp filed a 13F-HR form disclosing ownership of 1,672,491 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $94,478,985 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,166,799 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 43.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,672,491 505,692 43.34 94,479 36.25 0.0675
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,166,799 271,837 30.37 69,343 43.06 0.0504
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 894,962 156,480 21.19 48,471 19.40 0.0360
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 738,482 69,001 10.31 40,594 -14.22 0.0326
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 669,481 39,496 6.27 47,326 14.29 0.0419
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 629,985 162,687 34.81 41,409 26.07 0.0365
2024-11-13 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 467,298 63,274 15.66 32,846 -1.25 0.0313
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 404,024 -72,507 -15.22 33,263 -20.08 0.0339
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 476,531 -103,400 -17.83 41,620 -25.57 0.0422
2024-02-13 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 579,931 56,532 10.80 55,917 20.74 0.0610
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 523,399 17,438 3.45 46,310 5.60 0.0549
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 505,961 12,099 2.45 43,857 -8.68 0.0499
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 493,862 -8,262 -1.65 48,023 -7.58 0.0555
2023-02-09 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 502,124 -53,169 -9.57 51,963 10.39 0.0618
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 555,293 -43,066 -7.20 47,072 -5.07 0.0610
2022-08-12 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 598,359 -5,289 -0.88 49,586 6.54 0.0612
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 603,648 -521,126 -46.33 46,541 -53.17 0.0476
2022-02-08 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,124,774 41,888 3.87 99,374 18.73 0.0967
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,082,886 -132,988 -10.94 83,696 -17.50 0.0900
2021-10-12 2021-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,215,874 86,213 7.63 101,453 18.94 0.1098
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,215,874 86,213 101,453 0.1046
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,129,661 299,286 36.04 85,301 17.15 0.1033
2021-02-02 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 830,375 -184,481 -18.18 72,816 -5.69 0.0965
2020-11-05 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,014,856 -129,950 -11.35 77,210 -45.32 0.1237
2020-07-22 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,144,806 387,808 51.23 141,200 120.74 0.2447
2020-05-06 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 756,998 -109,093 -12.60 63,966 -12.65 0.1449
2020-02-03 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 866,091 8,866 1.03 73,228 26.74 0.1251
2019-11-04 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 857,225 -391,836 -31.37 57,777 -45.99 0.1088
2019-07-30 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,249,061 -12,847 -1.02 106,982 -4.56 0.2017
2019-06-19 2019-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,261,908 174,499 16.05 112,095 21.06 0.2229
2019-05-09 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,261,908 174,499 112,095
2019-02-07 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,087,409 -140,091 -11.41 92,593 -22.21 0.2195
2018-10-25 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,227,500 523,649 74.40 119,031 79.53 0.2216
2018-08-02 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 703,851 87,468 14.19 66,303 32.69 0.1375
2018-04-23 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 616,383 30,545 5.21 49,970 -4.34 0.1147
2018-02-08 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 585,838 10,900 1.90 52,239 -2.37 0.1244
2017-10-24 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 574,938 144,651 33.62 53,509 36.93 0.1376
2017-08-02 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 430,287 42,730 11.03 39,079 14.87 0.1043
2017-05-02 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 387,557 -86,505 -18.25 34,020 -13.37 0.0943
2017-02-06 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 474,062 122,469 34.83 39,271 20.73 0.1169
2016-11-01 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 351,593 -47,223 -11.84 32,529 4.84 0.0971
2016-08-04 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 398,816 -45,955 -10.33 31,028 -15.42 0.0977
2016-05-10 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 444,771 -727,546 -62.06 36,685 -70.13 0.1178
2016-05-04 2015-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,172,317 -295,520 -20.13 122,812 -20.56 0.3187
2016-02-03 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,172,317 122,812
2015-11-05 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,467,837 -280,208 -16.03 154,593 -35.34 0.4478
2015-08-04 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,748,045 -24,051 -1.36 239,098 8.27 0.6206
2015-05-04 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,772,096 595,536 50.62 220,839 107.63 0.6487
2015-02-13 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,176,560 21,164 1.83 106,361 27.57 0.3588
2014-11-12 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,155,396 208,123 21.97 83,373 41.48 0.3279
2014-08-11 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 947,273 35,990 3.95 58,930 -5.19 0.2448
2014-05-12 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 911,283 -58,014 -5.99 62,159 -8.84 0.2732
2014-08-08 2013-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 969,297 265,400 37.70 68,190 34.23 0.3306
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 969,297 68,190
2013-11-12 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 703,897 -14,308 -1.99 50,800 26.90 0.2754
2013-08-12 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 718,205 718,205 40,033 0.2605
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.